Skip to content

Author

Luis Antonio Cancel Treviño

We have 1 of 1 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Innovative Therapies for HER2-altered Non-Small Cell Lung Cancer: a Narrative Review.

A narrative review summarizes the clinicopathological features of HER2-altered NSCLC, critically evaluates emerging HER2-targeted therapies, and discusses future treatment directions.

Oscar Arrieta, E. Caballé-Pérez, L. Cabrera-Miranda et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.